Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Clinical trial NCT03325556 · COMPLETED

Trial details

NCT number: NCT03325556
Sponsor: ACADIA Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dementia-related Psychosis

Start date: 2017-09-27
Primary completion: 2019-07-31
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.